Results 101 to 110 of about 1,795 (205)

The expanding role of Wnt signaling in bone metabolism [PDF]

, 2013
Robling, Alexander G.
core   +1 more source

Osteoporosis Therapy: Bone Modeling during Growth and Aging [PDF]

, 2017
Hiromi Oda, Toshihiro Sugiyama
core   +1 more source

Biologics: Teriparatide and Newer Anabolics. [PDF]

Indian J Orthop, 2023
Jha SS.
europepmc   +1 more source

Morphea-like skin lesions reported in the Phase III Long-term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis.

Journal of American Academy of Dermatology, 2020
K. Saag, T. de Villiers, P. Alexandersen, H. Jacobe, C. Kovarik, V. Werth, A. Leung, A. Desai-Merchant, Julie Mattaliano, D. Gurner   +9 more
semanticscholar   +1 more source

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis [PDF]

, 2015
A. Sakai, F. Fukuda, H. Mizunuma, H. Saito, H. Tsurukami, M. Ito, null null, S. Ikeda, T. Inoue, T. Nakamura, T. Tomomitsu   +10 more
core   +1 more source

Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk. [PDF]

J Bone Miner Res, 2022
Eastell R, Vittinghoff E, Lui LY, Ewing SK, Schwartz AV, Bauer DC, Black DM, Bouxsein ML.   +7 more
europepmc   +1 more source

Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits

Calcified Tissue International, 2018
Christina Vrahnas, P. Buenzli, T. Pearson, B. Pennypacker, M. Tobin, K. Bambery, L. Duong, N. Sims   +7 more
semanticscholar   +1 more source

Targeting Cathepsin K to Accelerate Diabetic Wound Healing. [PDF]

ACS Pharmacol Transl Sci
Chenchar A, Mattos Pereira V, Apte A, Lyttle BD, Vaughn AE, Lehmann T, Bardill JR, Zgheib C, Liechty KW, Roballo KCS, Zhang Z, Alexander BM, Nair S.   +12 more
europepmc   +1 more source

Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives. [PDF]

Int J Mol Sci, 2022
Mijanović O, Jakovleva A, Branković A, Zdravkova K, Pualic M, Belozerskaya TA, Nikitkina AI, Parodi A, Zamyatnin AA.   +8 more
europepmc   +1 more source

Treatment-related changes in total hip bone mineral density are applicable to trials of varied study designs and to drugs with differing mechanisms of action: meta-regression results from the FNIH-ASBMR SABRE study. [PDF]

J Bone Miner Res
Vilaca T, Lui LY, Schini M, Ewing SK, Thompson A, Vittinghoff E, Bauer DC, Black DM, Bouxsein ML, Eastell R.   +9 more
europepmc   +1 more source